Medicenna Therapeutics Corp (NASDAQ:MDNA) Stock Extends Sell-Off: Down 32% in a Month
Medicenna Therapeutics Corp (NASDAQ:MDNA) dropped 10%, and in a month, the stock has shed 32%. The company announced the publication
Read more
NASDAQ:MDNA
DRP Journal
Discover Research Profit